Feature|Articles|June 9, 2025
Fully Remote Telehealth Cancer Clinical Trial Aims to Expand Treatment Access Nationwide
Author(s)Tony Berberabe, MPH
Fact checked by: Sabrina Serani
A groundbreaking telehealth trial offers remote access to innovative pancreatic cancer treatment, enhancing patient participation and care coordination nationwide.
Advertisement
Advertisement
A fully remote phase 2 telehealth trial (NCT06906562)1 that delivers oral pancreatic treatment directly to patients’ homes while coordinating care with local oncologists was launched recently at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and the Richard J. Solove Research Institute (OSUCCC-James). The trial, which opened May 8, 2025, seeks to enroll patients with FGFR-mutated pancreatic cancer.
Advertisement
Advertisement